In-depth knowledge of the business and regulation of the healthcare and life sciences sectors
With scientific advances, ever-changing government regulation, as well as strict ethical considerations, navigating healthcare and life sciences legislation is rarely straightforward. Therefore, we make sure our legal advice is based on a comprehensive knowledge of current developments in the industry.
Our lawyers take a multidisciplinary approach covering a range of angles: corporate and commercial, regulatory and public law, competition, EU Law, intellectual property, M&A and compliance. We know that sometimes you will have to move fast to get a deal done, or to respond to an issue, so we focus on making sure you get a straight answer quickly.
Our lawyers advise national and international pharmaceutical companies, hospitals, healthcare and cosmetics groups. We also advise private equity firms, investors and financial advisors to the sector.
Our specialisation includes:
- M&A and corporate
- Commercial contracts
- Finance
- Regulatory law
- Litigation and product liability
- Competition and EU Law
- Data protection
- Intellectual property
- Tax.
Our experience includes advising:
- Ysios Biofund on its Investment in the pharmaceutical company AM-Pharma B.V.
- Capza on its investment on the healthcare group Clínicas Dorsia, Clínicas Eva and Clínicas Origen.
- European Investment Bank and ICO on the amendment of the credit agreement granted to the pharmaceutical company Pharma Mar for financing R&D activities.
- Ventech, LSP, Roche, Novartis and Ysios BioFund on its Investment in Cellerix.
- Moira Capital Partners on its investments in the healthcare company Grupo Dermatológico Pedro Jaén and in Euroespes.
- The shareholders of Terapias Médicas Domiciliarias, S.L. on the transfer of the shares of the company on favour of Ribera Salud, S.A.
- Pharmexx International Spain, SLU. on the personnel restructuring process, involving several pharmaceutical laboratories in Spain.
- An important Spanish laboratory on the defense of the claim filed against the company and its directors.
